Ingersoll Rand Acquisition of ILC Dover

Ingersoll Rand Acquisition of ILC Dover

Pharmaceutical Technology

Ingersoll Rand has signed an agreement for the acquisition of ILC Dover from investment company New Mountain Capital for $2.325bn in cash upfront. The acquisition also includes an earnout based on meeting specific operating efficiency metrics in 2024. This platform will comprise the remaining P&ST businesses, representing revenue of $1bn. We are confident about the unique quality of our Company Profiles.

#SCIENCE #English #EG
Read more at Pharmaceutical Technology